First-, and Second-, and Third-Line Agents in mCRC
Medical experts discuss treatment-related toxicity management strategies in mCRC.
Implementing Targeted Therapies Into mCRC Treatment Algorithm
Ben George, MD, and John L. Marshall, MD, analyze the use of targeted therapies as an alternative to chemotherapy in mCRC treatment.
Navigating DLBCL Treatment Strategies for Patients Experiencing Resistance to Therapy
In his closing thoughts, Dr Gordon discusses navigation of treatment resistance in DLBCL management.
Additional Treatment Strategies and Collaborative Care for Patients with DLBCL
The impact of collaborative care in DLBCL treatment is explored by a medical expert.
Challenges in Diabetes Therapy Adherence: Impact on Early Intervention and Long-Term Visual Outcomes
Joseph M. Coney, MD, FACS, discusses the challenges physicians encounter when treating diabetic macular edema and the impact of the disease on patients’ quality of life.
Chemoimmunotherapy Timing: Pre or Post Surgery for Patients With NSCLC
Experts deliberate on the optimal timing of chemoimmunotherapy and if it should be before or after surgery.
Neoadjuvant Therapy in Early NSCLC Treatment
A panel discusses the role of neoadjuvant therapy in the current treatment approach for early stages of NSCLC.
Supportive Care, Decision-Making, and Fatigue Management
Providers speak to the importance of encouraging patients to self-report adverse reactions and participate in shared decision making.
Addressing the Impact of Platinum Shortages in mNSCLC Treatment
Experts address the impact of platinum shortages, 4-cycle platinum chemotherapy, and available treatments beyond platinum chemotherapy.
Key Considerations for Future CKD Treatment Approach
Expert panelists share final points of emphasis regarding treatment for CKD.
Early CKD Intervention Limiting Down-The-Line Costs Associated With ESRD Care
Medical experts highlight the financial benefit of early CKD intervention.
Unmet Needs in Current CKD Treatment Landscape
Barriers inhibiting optimal CKD treatment for patients are underlined.
The Impact of Clinical Pathways on Healthcare Resource Allocation in HCC Management
Ghassan Abou-Alfa, MD, MBA, and Mohamed Salem, MD, provide insights regarding potential clinical pathway-driven challenges associated with HCC management.
Evaluating Clinical Pathway Implementation in HCC Treatment
A panel of medical experts open a discussion surrounding key treatment strategies in management of hepatocellular carcinoma (HCC).
Targetable Mutations Investigated Or Utilized in mCRC
Medical experts explore the main treatment goals and modalities beyond pharmacotherapies for mCRC treatment, and discuss targetable mutations being explored in mCRC.
Addressing Barriers to Health Equity: The Role of Timely Diagnosis and Health Literacy in Managing Diabetic Eye Disease
Joseph M. Coney MD, FACS, discusses health equity considerations for patients with diabetic macular edema and the critical role a timely diagnosis and sufficient health literacy plays in effective therapy.
Emerging Therapies for Patients with PV
In his final thoughts, Dr Gerds discusses emerging therapies for the treatment of PV.
Understanding and Treating Uncontrolled PV
Uncontrolled PV is highlighted by a key opinion leader.
DLBCL Treatment in Elderly Patients with Multiple Comorbidities
Treatment of DLBCL amid comorbidities in elderly patients is highlighted.
Utilizing Bispecific Treatment in Relapsed DLBCL Patients
Dr Gordon discusses use of bispecifics for management of patients with relapsing DLBCL.
Multidisciplinary Care Driving Metastatic Colorectal Cancer Treatment
Collaborative care from medical and surgical oncologists as well as supportive care teams provides an optimal treatment environment for patients facing mCRC diagnosis.
Immunotherapy in Surgical and Radiation Patients With NSCLC
Experts review their considerations when adding immunotherapy to both surgical patients and radiation patients with NSCLC.
Early-Stage NSCLC Standard Treatments
Experts discuss the current standard treatment options for patients diagnosed with early-stage NSCLC [non-small cell lung cancer].
Patient Eligibility for Utilizing Anti-CTLA4-Containing Regimens
A conversation on patient tolerance of CTLA-4 immunotherapies, alongside an exploration of treatment-related adverse reactions is discussed by a panel of experts.
Quality Measures Driving Quality CKD Care
John Anderson, MD, discusses the management of quality care for patients with CKD.
Payer Programs Supporting CKD Treatment
Ken Cohen, MD, illustrates payer programs designed to support patient care in CKD treatment.
Closing Thoughts from Panelists
Closing thoughts from all panel members.
Pros and Cons of Utilizing Telehealth for Treating Acne
A conversation on the pros and cons of telehealth in acne treatment.
Benefits and Limitations Surrounding Current Treatment for PV
Dr Gerds explores the pros and cons of the present treatment approach for PV.
Emotional and Physical Challenges Affecting Caregivers and Patients Diagnosed With mCRC
Panelists highlight challenges facing both patients and caregivers associated with colorectal cancer treatment.
